Birgit Grund

[email protected]

612-624-8076

Statistics

383 Ford Hall

224 Church St SE
Minneapolis, MN 55455

Collegiate Affiliation

Statistics

Educational Background & Specialties

Open Close

Educational Background

Ph.D.: Statistics, Humboldt University, 1987

Specialties

Design and analysis of clinical trials, in HIV, Ebola, and COVID-19
Design of experiments
Nonparametric curve estimation and smoothing methods

Publications

Open Close

Publications

Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, De Castro N, Johnson M, Sharma A, Carr A for the INSIGHT SMART Body Composition Substudy Group. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART Body Composition Substudy. J Bone Min Res 2013; DOI 10.1002/jbmr.1861.
Grund B, Sabin C. Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Current Opinion in HIV & AIDS.2010;5(6):473-9
Grund B, Peng G, Gibert C, Hoy J, Isaksson R, Shlay J, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009;23(12):1519-29
Wright E, Grund B, Robertson K, Brew B, Roediger M, Bain M, et al. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010;75(10):864-73
Burman W, Grund B, Roedige M, Friedland G, Darhyshire J, Wu A, et al. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. JAIDS-Journal of Acquired Immune Deficiency Syndromes. 2008;47(2):185-93.
Burman W, Grund B, Neuhaus J, Douglas J, Friedland G, Telzak E, et al. Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial. JAIDS-Journal of Acquired Immune Deficiency Syndromes. 2008;49(2):142-50
Carr A, Grund B, Neuhaus J, El-Sadr W, Grandits G, Gibert C, et al. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS. 2008;22(2):257-67
El-Sadr W, Grund B, Neuhaus J, Babiker A, Cohen C, Darbyshire J, et al. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial. Annals of Internal Medicine. 2008;149(5):289-W62
Lundgren J, Babiker A, El-Sadr W, Emery S, Grund B, Neaton J, et al. Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up. Journal of Infectious Diseases. 2008;197(8):1145-55.
Martinez E, Visnegarwala F, Grund B, Thomas A, Gibert C, Shlay J, et al. The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS. 2010;24(3):353-63
Bibliography: Grund, Birgit.

Awards

Open Close

Courses

Open Close